
==== Front
Clin Exp Reprod Med
Clin Exp Reprod Med
CERM
Clinical and Experimental Reproductive Medicine
2233-8233
2233-8241
Korean Society for Reproductive Medicine

38599889
10.5653/cerm.2023.06429
cerm-2023-06429
Original Article
Metabolomic profiling of embryo culture media in patients with repeated implantation failure during assisted reproductive technology cycles
Metabolomics in ART: repeated implantation failure
Nami Sheyda 1 *
http://orcid.org/0000-0001-6684-2292
Govahi Azam 2 *
Najjar Nabaa 1
Ghasemi Samaneh 3
http://orcid.org/0009-0003-7692-0698
Rezaei Farshid 4
http://orcid.org/0000-0002-7489-7186
Amjadi Fatemehsadat 3 5
http://orcid.org/0000-0003-0284-6432
Taheripak Gholamreza 1
1 Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran
3 Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), Iran University of Medical Sciences, Tehran, Iran
4 Department of Biology, Payam Noor University, Tehran, Iran
5 Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Corresponding author: Gholamreza Taheripak Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran Tel: +98-21-88622689 Fax: +98-21-88622689 E-mail: taheripak.gh@iums.ac.ir
Co-corresponding author: Fatemehsadat Amjadi Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran 14496-14535, Iran Tel: +98-21-88622689 Fax: +98-21-88622689 E-mail: amjadi.bh@gmail.com
* These authors contributed equally to this study.

* This work was supported by the Iran University of Medical Sciences (grant no: 97-4-4-13477).

9 2024
11 4 2024
51 3 260267
5 8 2023
11 11 2023
8 12 2023
© 2024. THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective

This study investigated the metabolic status of the spent culture media from embryos of patients with repeated implantation failure (RIF) undergoing in vitro fertilization–intracytoplasmic sperm injection cycles in comparison with the embryos from healthy fertile women.

Methods

Metabolite levels in spent culture media were assessed and compared between embryos from RIF patients (n=35) and oocyte donors as controls (n=15). Protein levels of insulin-like growth factor 1 (IGF-1) were determined using Western blotting. Concentrations of glucose, pyruvate, and lactate were measured using spectrophotometry. Ionic colorimetric assay kits were utilized to analyze the concentrations of sodium, chloride, calcium, and magnesium ions. High-performance liquid chromatography was employed to measure the concentrations of glutamic acid, aspartic acid, methionine, phenylalanine, and histidine.

Results

Glucose consumption and lactate secretion were higher in the control group than in the RIF group. The magnesium concentration was significantly higher in the control group than in the RIF group, but glutamic acid and aspartic acid concentrations were lower in the control group than in the RIF patients (p<0.05). The levels of IGF-1, sodium, calcium, chloride, methionine, histidine, and phenylalanine did not show statistically significant differences between the two groups.

Conclusion

The metabolic profile of the culture medium of the embryos in the RIF group differed from that of the control group. These findings suggest potential factors that may affect implantation capacity in RIF patients and provide a new perspective on embryo selection.

Culture media
Embryo
Metabolomics
Repeated implantation failure
==== Body
pmcIntroduction

Despite rapid advances in assisted reproductive technology (ART), the implantation rate remains suboptimal [1]. Many couples undergoing ART cycles continue to experience repeated implantation failure (RIF) [2], which is one of the most widely challenging problems at infertility centers. RIF is defined as the inability to achieve clinical pregnancy after a minimum of three in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles, involving the transfer of at least six high-quality embryos [3-5]. Various factors have been proposed as potential causes of implantation failure, including embryo-related factors and poor endometrial receptivity [3,5,6].

The selection of high-quality embryos is an important part of the strategy for managing RIF patients [2,7]. Improvement in embryo selection methods directly contributes to increased pregnancy rates [8]. However, the current standard for embryo selection primarily relies on the morphological appearance, such as the presence of several cells and speed of cleavage divisions, level of fragmentation and vacuolation, and the blastomeres' shape and size. However, research has shown that this approach is far from perfect, with embryo implantation rates ranging from 20% to 40% [7].

The evaluation of metabolomic profiles in the embryo culture medium has emerged as an effective method for predicting embryo viability and developmental potential [9]. Metabolomics involves comprehensive analyses of interactions between various small molecules or biomarkers, known as metabolites, including amino acids, lipids, nucleotides, and signaling molecules [10,11].

Several metabolic parameters associated with the culture medium of developing embryos have been investigated. For instance, Gardner et al. [12] reported higher glucose uptake in high-quality human blastocysts, while Brison et al. [13] found that higher asparagine levels and lower glycine and leucine levels in the culture medium were directly linked to pregnancy. In a study focusing on identifying metabolites impacting embryo implantation, the culture medium of embryos with positive and negative implantation outcomes was compared using electrospray ionization mass spectrometry. Specific biochemical markers were discovered in the culture medium of successfully implanted embryos, demonstrating the potential for predicting the implantation potential of human embryos [14]. Another study examining the metabolomic profile of culture medium from thawed embryos revealed that the characteristics of the medium were independent of embryo morphology and correlated with the embryo's implantation potential in frozen-thawed embryo transfer cycles [15]. These studies indicate that the embryonic culture environment is influenced by the embryo's reproductive potential and underscore the importance of identifying key metabolites to predict embryos with high implantation potential, offering new possibilities for successful pregnancies in patients experiencing RIF [9].

To the best of our knowledge, no previous investigations have explored metabolites of day 3 embryos in subjects with RIF. Hence, this study aimed to evaluate and compare the metabolomic profiles of spent embryo culture medium between individuals with unexplained RIF and healthy individuals with successful pregnancies.

Methods

1. Study design

This study received approval from the Ethical Committee of the Iran University of Medical Sciences (number: IR.Iums.fMD.REC.1398.149). Written informed consent was obtained from all participants. The study included 35 patients with unexplained RIF, defined as the failure to achieve implantation after at least four good-quality embryo transfers in three consecutive embryo transfer cycles. The control group consisted of 15 oocyte donors with proven fertility, having at least one live birth following a natural pregnancy. In the RIF group, participants were excluded if they had any identifiable causes such as polycystic ovary syndrome, ovarian tumors, autoimmune disorders, chromosomal anomalies, sexually transmitted diseases, polyps, fibroids, endometriosis, adenomyosis and malformation of the uterus. All subjects had a range in age from 18 to 38 years, and a body mass index below 30 kg/m2. None of the participants had any pre-existing medical conditions or abnormalities. Both groups met the inclusion criteria of regular menstrual cycles, a normal uterine cavity, an endometrial thickness of 7 mm or greater in ultrasound, normoresponsiveness to the stimulation protocol, and the absence of intrauterine adhesions or inflammation. They also had regular serum levels of follicle-stimulating hormone, estrogen, progesterone, and thyroid-stimulating hormone. The male partners of the couples had normal semen analysis results according to the World Health Organization guidelines [16]. Ovarian stimulation was initiated using a standard antagonist protocol for both groups. Oocytes were retrieved 36 hours after human chorionic gonadotropin administration, and mature oocytes at the metaphase II stage were subjected to an ICSI procedure. Subsequently, the embryos were cultured in SAGE 1-Step medium (Origio media) under controlled conditions of 6% CO2, 5% O2, and 37 °C [17]. Fertilization was assessed 16 to 18 hours after ICSI by observing the presence of two pronuclei, and embryo development was monitored until the third day [18]. Finally, the spent embryo culture medium was stored at –80 °C for experiments. During the embryo culture process, the drops of the culture medium were 50 mL, with four embryos cultured in each drop. Each drop served as a sample for analysis. Ultimately, the samples were pooled together, and three samples were analyzed for each group. Different volumes ranging from 10 to 20 mL were used for each analysis.

2. Protein extraction and Western blot analysis

The protease inhibitor cocktail was sourced from Roche. Polyvinylidene diﬂuoride membranes were from Millipore, while enhanced chemiluminescence (ECL) reagents were from Amersham Pharmacia Corp. All other reagents were acquired from Sigma Aldrich. To experiment, 20 to 30 μg of total protein was separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and subjected to immunoblotting using an anti-insulin-like growth factor 1 (IGF-1) antibody (Elabscience). The protein concentration of all samples was determined using a Bradford assay (Sigma Aldrich) with bovine serum albumin as the standard. Total proteins were then separated by 8% SDS-PAGE and transferred onto a polyvinylidene difluoride membrane (Sigma Aldrich).

For membrane blocking, a solution containing 0.1% Tween 20 in Tris-buffered saline with 2% skim milk was used for 75 minutes. The membranes were then incubated overnight with a 1:300 dilutions of anti-IGF-1 polyclonal antibody (Elabscience), followed by incubation with a 1:1,000 dilution of mouse anti-rabbit immunoglobulin G (IgG)-horseradish peroxidase (HRP) antibody (Santa Cruz Biotechnology Inc.) for 75 minutes. Immunoblotted protein bands were visualized using ECL, and the protein bands were quantified using gel-analyzer version 2010a software (National Institutes of Health), relative to the internal reference [19]. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) housekeeping gene was used for normalization.

3. Metabolome analysis

1) Glucose concentration assay

Glucose content was determined using a glucose colorimetric assay kit (Pars Azmun). In this experiment, the exposure of glucose to glucose oxidase leads to the production of H2O2, which is the substrate of peroxidase, which subsequently converts 4-aminoantipyrine to quinoneimine. The amount of quinoneimine is proportional to the glucose concentration.

The assay was performed by incubating a mixture of 10 μL of diethyl pyrocarbonate (DEPC)-treated water, 10 μL of embryo culture medium or standard samples, and 1,000 μL of glucose assay reagent (250 mmol/L phosphate=buffer, 5 mmol/L phenol, 0.5 mmol/L 4-aminoantipyrine, 10 KU/L glucose oxidase, 1 KU/L peroxidase) for 20 minutes at 20 to 25 °C. The absorbance of the standards and samples was then measured at a wavelength of 546 nm (UV-2600i/2700i; Shimadzu Corp.), relative to the blank. The cuvette used in this experiment had a path length of 1 cm.

2) Lactate concentration assay

To measure the amount of lactate, a lactate assay kit was used (ZellBio Gmbh). In this experiment, lactate oxidase catalyzed the conversion of lactate into pyruvate and H2O2. The presence of peroxidase facilitated the reaction between hydrogen peroxide, 4-aminoantipyrine, and 2,4,6-tribromo-3-hydroxybenzoic acid (TBHB), resulting in the formation of a red substance, chinonimine, the concentration of which was directly proportional to the lactate amount.

For the assay, 10 μL of samples and standards were mixed with 1,000 μL of lactate assay reagent R1, which contained 150 mmol/L Tris buffer (pH 7.5), >30 KU/L lactate oxidase, >1 KU/L peroxidase, 0.3 mmol/L 4-aminoantipyrine, and 2.5 mmol/L TBHB. The mixture was then incubated at 37 °C for 10 minutes. The absorbance of the samples was measured at a wavelength of 546 nm using a cuvette with a path length of 1 cm.

3) Pyruvate concentration assay

The pyruvate content in the study samples was measured using a pyruvate assay kit (MAK071; Sigma Aldrich). A mixture of 46 μL of pyruvate assay buffer, 2 μL of pyruvate probe solution, and 2 μL of pyruvate enzyme mix was prepared and incubated for 30 minutes at 37 °C. The absorbance of all samples was then analyzed at a wavelength of 546 nm using a cuvette with a path length of 1 cm.

4. Inorganic ion consumption determination

For the measurement of ionic concentrations in all samples, a two-solution method employing two ion assay reagents was utilized. Reagent 1 comprised 0.8 mol/L ethanolamine and detergent with a pH of 10.7. Reagent 2 consisted of 0.06 mmol/L 2-cresolphthalein, 7 mmol/L 8-hydroxyquinoline, and 20 mM HCl with a pH of 1.1. During the experiment, a purple complex formed as a result of the reaction between the ion and cresolphthalein complexone in an alkaline environment. The concentration of this complex was directly proportional to the corresponding ion concentration. Initially, a mixture of 20 μL of sample, 20 μL of DEPC-treated water, and 1,000 μL of reagent 1 was prepared and incubated at room temperature for 5 to 30 minutes. The absorbance of the mixture was then measured at 570 nm. Subsequently, 250 μL of reagent 2 was added to the aforementioned mixture. After re-incubation of the sample for an additional 5 to 30 minutes, the absorbance was determined again at 570 nm. Calcium, sodium, magnesium, and chloride ions were analyzed separately using an inorganic ion assay kit (Pars Azmun). This kit was designed to measure ions within the range of 0.2 to 20 mg/dL. Additionally, a cuvette with a path length of 1 cm was used in this experiment.

5. High-performance liquid chromatography

In this study, the concentration of histidine, methionine, phenylalanine, glutamic acid, and aspartic acid in the embryo culture medium of the RIF and control groups was determined using high-performance liquid chromatography (HPLC). A Zorbax AAA column (150 mm×4.6 mm, Agilent 1100; Agilent) and a fluorescence detector were used to quantify the amino acids. Mobile phase 1 was 10 mM sodium dihydrogen phosphate and ethanol with a pH of 7.2 (80:20, v/v), while mobile phase 2 comprised 10 mM sodium dihydrogen phosphate buffer and ethanol with a pH of 7.2 (50:50, v/v). The absorption of amino acids was measured at an excitation wavelength of 340 nm and an emission wavelength of 450 nm at a temperature of 40 °C. The amount of amino acids was determined based on the area under the curve using their respective standard curves [20].

6. Statistical analysis

Data analysis was performed using SPSS version 24.0 (IBM Co.) and Prism 8 software (GraphPad Software Inc.). All data were reported as mean±standard deviation. A p<0.05 was considered to indicate statistical significance. The normality of the data was assessed with the Kolmogorov-Smirnov test, and if the data were normally distributed, the independent sample t-test was used. If the data were not normally distributed, the nonparametric Mann-Whitney test was employed.

7. Availability of data and material

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Results

1. Study population

Demographic and clinical data of study groups are summarized in Table 1. Data analysis showed no significant difference between the two groups (p>0.05).

2. IGF-1 protein level

For the evaluation of IGF-1 protein expression, total protein content was measured based on the Bradford protein assay standard curve and regression linear equation. No significant difference was found in the IGF-1 protein level of the embryo culture medium obtained from the RIF and control groups. The corresponding protein bands generated by Western blotting and densitometry graphs of IGF-1 protein levels in both groups are shown in Figure 1.

3. Glucose, pyruvate, and lactate assay

The RIF group had higher glucose (significant) and pyruvate (non-significant) concentrations than the control group, but significantly lower Lactate concentrations (p<0.05) (Figure 2).

4. Inorganic ion concentration assay

The concentrations of calcium, magnesium, sodium, and chloride in the embryo culture medium of the RIF and control groups were determined through ion colorimetric assay kits. No significant difference was noted in calcium, chloride, and sodium concentrations between the RIF group and the control group, but the magnesium concentration was significantly lower in the RIF group than in the controls (p<0.05) (Figure 3).

5. Amino acid concentration assay

HPLC showed that there were no significant differences in histidine, methionine, and phenylalanine concentrations between the RIF group and the control group, but the glutamic acid and aspartic acid levels were 50% and 36% higher in the RIF group than in the control group, respectively (p<0.01 and p<0.001) (Figure 4).

Discussion

In this study, we examined the concentration of several metabolites, including glucose, lactate, glutamic acid, aspartic acid, and magnesium, in the embryo culture medium. Significant differences were found between the RIF patients and controls. However, the concentrations of IGF-1, sodium, calcium, chloride, methionine, histidine, and phenylalanine did not show significant differences between the two groups.

IGF-1 plays an important role in early embryonic development through processes such as inhibiting apoptosis and regulating glucose metabolism [21-23]. Agrogiannis et al. [24] (2014) showed that the expression of IGF-1 and its receptors are activated on the third embryonic day. At this stage, IGF-1 binds to its receptors and stimulates amino acid and glucose consumption. In addition, IGF-1 expression affects differentiation, blastocyst formation, and embryo implantation [24-26]. However, if its concentration in the culture medium is too high, it will have a toxic effect on the embryo [27]. In this study, there was no significant difference in IGF-1 expression between the RIF and control groups. However, comparing the consumption of this metabolite between the RIF and control groups in the blastocyst stage may lead to reliable results regarding the effect of this factor on implantation potential.

In this study, the RIF group exhibited less pyruvate consumption and lactate secretion than the control group. Pyruvate is the main source of energy in the early stages of embryo development. High consumption of pyruvate and secretion of lactate during the early stages of embryonic development (up to the 8-cell stage) activate the tricarboxylic acid cycle in the mitochondria and respiratory chain [28]. Previous research by Gott et al. [29] (1990) demonstrated that arrested or degenerated embryos displayed lower pyruvate uptake and lactate production compared to normally developed embryos. Additionally, embryos reaching the blastocyst stage showed significantly higher pyruvate uptake than those not reaching this stage [30]. Adenosine triphosphate (ATP) production in embryos relies primarily on pyruvate oxidation, with exogenous pyruvate playing a vital role. However, a substantial portion of pyruvate is converted to lactate rather than being used for oxidative phosphorylation. Lactate serves as an energy source and a potent cytosolic reductant, protecting cells from oxidative stress and damage [28].

The decreased pyruvate consumption and lactate secretion observed in RIF embryos may negatively impact their implantation ability. Pyruvate and lactate play crucial roles in early embryonic development, and reduced levels of these substances could hinder successful implantation. Furthermore, glucose is another important energy source for embryos. However, until the 8-cell stage, glucose is not considered the main energy source and its consumption is less than pyruvate. Subsequently, glucose consumption increases significantly during the 8-cell, blastocyst, and implantation stages [31], which is due to the synthesis of glucose transporters and activation of the glycolysis pathway [32]. Our findings indicate lower glucose absorption in the RIF group than in the control group. Chi et al. [33] (2020) showed that embryos cultured in a glucose-containing culture medium can develop to the blastocyst stage, while embryos in a glucose-free culture medium can only develop to the 4-cell stage. Lower glucose absorption may affect the quality of the embryo and its implantation ability.

Numerous studies have highlighted the significance of ion concentrations in the embryo culture medium for embryo development and implantation [34,35]. In line with this, our current research found that the RIF group exhibited lower levels of sodium and chloride than the control group, which is attributed to elevated consumption of these ions. The outcomes of our study, coupled with previous research, indicate that increased intracellular levels of sodium and chloride can disrupt cellular processes. Specifically, higher sodium and chloride concentrations impede protein synthesis, affecting embryo growth and differentiation [36,37]. Additionally, our study identified a noteworthy disparity in magnesium and calcium concentrations between the RIF and control groups. The RIF group displayed reduced magnesium levels and elevated calcium levels, suggesting different consumption patterns of these ions by the embryos. These findings are consistent with previous studies, emphasizing the pivotal role of calcium in fertilization, the cleavage stage, and implantation. Moreover, earlier research has demonstrated that magnesium, acting as a chelating agent, can inhibit calcium's function in signaling pathways, ultimately impacting embryo growth and implantation [38,39]. Furthermore, excessive magnesium consumption by the embryo can hinder calcium usage in mitochondria, inhibiting ATP production along the electron transfer chain and subsequently reducing successful implantation [40].

Regarding amino acid consumption, our study identified higher concentrations of aspartic acid and glutamic acid in the culture medium of embryos from the RIF group than in those from the control group. This discrepancy suggests greater consumption of these amino acids by embryos from healthy women compared to those with from women with RIF. However, no significant differences were observed in the consumption of methionine, phenylalanine, and histidine between the two groups. Notably, recent investigations into the metabolic characteristics of culture medium used during IVF procedures have demonstrated that specific amino acids can enhance in vitro embryo development, benefiting pre-implantation embryos in various ways [41]. Moreover, some studies have highlighted the role of certain amino acids as intracellular pH-regulating buffers in embryos, influencing embryo differentiation and blastocyst implantation [41,42]. For instance, a study exploring the relationship between culture medium for 3-day human embryos and implantation potential revealed that amino acid concentrations could be used to predict the implantation rate; it also found significant differences in amino acid levels, including aspartic acid, serine, histidine, and alanine, between pregnant and non-pregnant groups [43]. The difference observed in the consumption of aspartic acid and glutamic acid by embryos in the RIF group in our study may be related to embryo competence.

Overall, our study's findings shed light on the distinct metabolic profile of the culture medium in the RIF group compared to the control group. These results provide a fresh perspective on potential factors influencing embryo competence in implantation among RIF patients.

The authors would like to thank Iran University of Medical Sciences (IUMS), Tehran, Iran for their cooperation throughout the period of study.

Figure 1. The insulin-like growth factor 1 (IGF-1) protein expression in culture medium from the repeated implantation failure (RIF) and control groups. Values are presented as mean±standard deviation of at least three replicates. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Figure 2. Glucose, pyruvate, and lactate concentrations in the repeated implantation failure (RIF) and control groups. Values are presented as mean±standard deviation of three replicates. a)p<0.05; b)p<0.01.

Figure 3. Comparison of (A) calcium, and magnesium and (B) sodium and chloride concentrations between the repeated implantation failure (RIF) and control groups. Values are presented as mean±standard deviation of three replicates. a)p<0.05.

Figure 4. Comparison of histidine, methionine, phenylalanine, glutamic acid, and aspartic acid concentrations between the repeated implantation failure (RIF) and control groups. Values are presented as mean±standard deviation of three replicates. a)p<0.01; b)p<0.001.

Table 1. Demographic and clinical data of the study women and sperm parameters of their partners

Parameter	RIF group (n=35)	Control group (n=15)	p-value	
Age (yr)	31.4±4.2	29.79±4.6	0.23	
BMI (kg/m2)	25.27±5.3	26.3±4.53	0.51	
Duration of infertility (yr)	6.46±4.24	5.82±4.48	0.63	
FSH (mU/mL)	5.68±2.38	6.08±2.40	0.58	
TSH (mU/mL)	2.13±0.89	2.08±0.64	0.84	
Total dose of gonadotropin (IU)	1,567.6±422.10	1,622.369±510.04	0.69	
Duration of stimulation (day)	12.7±2.29	12.53±2.49	0.81	
Number of retrieved oocyte	13.9±7.68	12.4212±8.98	0.61	
Sperm count (million)	50.69±29.82	56.6±36.39	0.55	
Total sperm motility (%)	76.95±21.919	70.80±26.20	0.39	
Normal sperm morphology (%)	7.69±1.50	7.95±1.67	0.58	
Values are presented as mean±standard deviation.

RIF, repeated implantation failure; BMI, body mass index; FSH, follicle-stimulating hormone; TSH, thyroid-stimulating hormone.

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Author contributions

Conceptualization: SN, AG, NN, SG, FR, FA, GT. Data curation: SN, AG. Formal analysis: NN, SG, FR. Funding acquisition: GT. Methodology: SN, AG, FA, GT. Project administration: FA, GT. Visualization: NN, SG, FR. Writing-original draft: SN, AG. Writing-review & editing: FA, GT.
==== Refs
References

1 de Mouzon J Goossens V Bhattacharya S Castilla JA Ferraretti AP Korsak V Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE Hum Reprod 2010 25 1851 62 20570973
2 Abolghasemi H Aghaiipour M Nikougoftar M Amirizadeh N Mohammadi MT Rahmani S Leukoreduction in packed cells filtered by home-made Sci J Iran Blood Transfus Organ 2009 6 13 20
3 Coughlan C Ledger W Wang Q Liu F Demirol A Gurgan T Recurrent implantation failure: definition and management Reprod Biomed Online 2014 28 14 38 24269084
4 Zhang D Ma C Sun X Xia H Zhang W S100P expression in response to sex steroids during the implantation window in human endometrium Reprod Biol Endocrinol 2012 10 106 23216986
5 Margalioth EJ Ben-Chetrit A Gal M Eldar-Geva T Investigation and treatment of repeated implantation failure following IVF-ET Hum Reprod 2006 21 3036 43 16905766
6 Simur A Ozdemir S Acar H Colakoglu MC Gorkemli H Balci O Repeated in vitro fertilization failure and its relation with thrombophilia Gynecol Obstet Invest 2009 67 109 12 18957855
7 Kovacs P Embryo selection: the role of time-lapse monitoring Reprod Biol Endocrinol 2014 12 124 25510244
8 Conaghan J Chen AA Willman SP Ivani K Chenette PE Boostanfar R Improving embryo selection using a computer-automated time-lapse image analysis test plus day 3 morphology: results from a prospective multicenter trial Fertil Steril 2013 100 412 9 23721712
9 Seli E Vergouw CG Morita H Botros L Roos P Lambalk CB Noninvasive metabolomic profiling as an adjunct to morphology for noninvasive embryo assessment in women undergoing single embryo transfer Fertil Steril 2010 94 535 42 19589524
10 Wishart DS Proteomics and the human metabolome project Expert Rev Proteomics 2007 4 333 5 17552914
11 Ellis DI Goodacre R Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy Analyst 2006 131 875 85 17028718
12 Gardner DK Lane M Stevens J Schoolcraft WB Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potential Fertil Steril 2001 76 1175 80 11730746
13 Brison DR Houghton FD Falconer D Roberts SA Hawkhead J Humpherson PG Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover Hum Reprod 2004 19 2319 24 15298971
14 Cortezzi SS Cabral EC Trevisan MG Ferreira CR Setti AS Braga DP Prediction of embryo implantation potential by mass spectrometry fingerprinting of the culture medium Reproduction 2013 145 453 62 23404850
15 Li X Xu Y Fu J Zhang WB Liu SY Sun XX Non-invasive metabolomic profiling of embryo culture media and morphology grading to predict implantation outcome in frozen-thawed embryo transfer cycles J Assist Reprod Genet 2015 32 1597 605 26463877
16 Lu JC Huang YF Lu NQ WHO Laboratory Manual for the Examination and Processing of Human Semen: its applicability to andrology laboratories in China Zhonghua Nan Ke Xue 2010 16 867 71 21243747
17 Govahi A Amjadi F Nasr-Esfahani MH Raoufi E Mehdizadeh M Accompaniment of time-lapse parameters and cumulus cell RNA-sequencing in embryo evaluation Reprod Sci 2022 29 395 409 34642913
18 Ovarian Stimulation TEGGO Bosch E Broer S Griesinger G Grynberg M Humaidan P ESHRE guideline: ovarian stimulation for IVF/ICSI Hum Reprod Open 2020 2020 hoaa009 32395637
19 Hakimpour S Jelodar G Shabani R Pourheydar B Ajdary M Mehdizadeh M Study of vitamin D3 formulation prepared by phytosolve technique and its effect on CTRP6 gene expression in PCOS model J Drug Deliv Sci Technol 2022 73 103489
20 Drabkova P Andrlova L Kanďar R An HPLC method for the determination of selected amino acids in human embryo culture medium Biomed Chromatogr 2017 31 e3800
21 Lin TC Yen JM Gong KB Hsu TT Chen LR IGF-1/IGFBP-1 increases blastocyst formation and total blastocyst cell number in mouse embryo culture and facilitates the establishment of a stem-cell line BMC Cell Biol 2003 4 14 14499003
22 Zaraza J Oropeza A Velazquez MA Korsawe K Herrmann D Carnwath JW Developmental competence and mRNA expression of preimplantation in vitro-produced embryos from prepubertal and postpubertal cattle and their relationship with apoptosis after intraovarian administration of IGF-1 Theriogenology 2010 74 75 89 20138354
23 Bedzhov I Liszewska E Kanzler B Stemmler MP Igf1r signaling is indispensable for preimplantation development and is activated via a novel function of E-cadherin PLoS Genet 2012 8 e1002609 22479204
24 Agrogiannis GD Sifakis S Patsouris ES Konstantinidou AE Insulin-like growth factors in embryonic and fetal growth and skeletal development (review) Mol Med Rep 2014 10 579 84 24859417
25 Xie M McCoski SR Johnson SE Rhoads ML Ealy AD Combinatorial effects of epidermal growth factor, fibroblast growth factor 2 and insulin-like growth factor 1 on trophoblast cell proliferation and embryogenesis in cattle Reprod Fertil Dev 2017 29 419 30 26304178
26 Vailes MT McCoski SR Wooldridge LK Reese ST Pohler KG Roper DA Post-transfer outcomes in cultured bovine embryos supplemented with epidermal growth factor, fibroblast growth factor 2, and insulin-like growth factor 1 Theriogenology 2019 124 1 8 30317067
27 Irani M Nasioudis D Witkin SS Gunnala V Spandorfer SD High serum IGF-1 levels are associated with pregnancy loss following frozen-thawed euploid embryo transfer cycles J Reprod Immunol 2018 127 7 10 29574310
28 Hu K Yu Y Metabolite availability as a window to view the early embryo microenvironment in vivo Mol Reprod Dev 2017 84 1027 38 28722155
29 Gott AL Hardy K Winston RM Leese HJ Non-invasive measurement of pyruvate and glucose uptake and lactate production by single human preimplantation embryos Hum Reprod 1990 5 104 8 2324239
30 Madr A Cela A Klejdus B Pelcova M Crha I Zakova J Determination of pyruvate and lactate as potential biomarkers of embryo viability in assisted reproduction by capillary electrophoresis with contactless conductivity detection Electrophoresis 2015 36 1244 50 25639526
31 Conaghan J Handyside AH Winston RM Leese HJ Effects of pyruvate and glucose on the development of human preimplantation embryos in vitro J Reprod Fertil 1993 99 87 95 8283458
32 Pantaleon M Ryan JP Gil M Kaye PL An unusual subcellular localization of GLUT1 and link with metabolism in oocytes and preimplantation mouse embryos Biol Reprod 2001 64 1247 54 11259273
33 Chi F Sharpley MS Nagaraj R Roy SS Banerjee U Glycolysis-independent glucose metabolism distinguishes TE from ICM fate during mammalian embryogenesis Dev Cell 2020 53 9 26 32197068
34 Miao YL Williams CJ Calcium signaling in mammalian egg activation and embryo development: the influence of subcellular localization Mol Reprod Dev 2012 79 742 56 22888043
35 Byers SL Payson SJ Taft RA Performance of ten inbred mouse strains following assisted reproductive technologies (ARTs) Theriogenology 2006 65 1716 26 16271754
36 Ho Y Doherty AS Schultz RM Mouse preimplantation embryo development in vitro: effect of sodium concentration in culture media on RNA synthesis and accumulation and gene expression Mol Reprod Dev 1994 38 131 41 7521650
37 Lawitts JA Biggers JD Joint effects of sodium chloride, glutamine, and glucose in mouse preimplantation embryo culture media Mol Reprod Dev 1992 31 189 94 1554503
38 Lane M Gardner DK Inhibiting 3-phosphoglycerate kinase by EDTA stimulates the development of the cleavage stage mouse embryo Mol Reprod Dev 2001 60 233 40 11553924
39 Herrick JR Strauss KJ Schneiderman A Rawlins M Stevens J Schoolcraft WB The beneficial effects of reduced magnesium during the oocyte-to-embryo transition are conserved in mice, domestic cats and humans Reprod Fertil Dev 2015 27 323 31 24280268
40 Jouaville LS Pinton P Bastianutto C Rutter GA Rizzuto R Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming Proc Natl Acad Sci U S A 1999 96 13807 12 10570154
41 Edwards LJ Williams DA Gardner DK Intracellular pH of the mouse preimplantation embryo: amino acids act as buffers of intracellular pH Hum Reprod 1998 13 3441 8 9886531
42 Martin PM Sutherland AE Van Winkle LJ Amino acid transport regulates blastocyst implantation Biol Reprod 2003 69 1101 8 12801981
43 Huo P Zhu Y Liang C Yao J Le J Qin L Non-invasive amino acid profiling of embryo culture medium using HPLC correlates with embryo implantation potential in women undergoing in vitro fertilization Front Physiol 2020 11 405 32508665
